About Hemagen
Hemagen is a publicly listed company based in Columbia (United States) founded in 1985. It develops diagnostic kits for autoimmune and infectious diseases. Hemagen offers products and services including Veterinary Diagnostic Products and Human Diagnostic Products. Its focus areas include Diversified Diagnostics. Its legal entity is HEMAGEN DIAGNOSTICS INC.
Company details
Hemagen Diagnostics is a biotechnology company focused on development and manufacturing of human and veterinary diagnostic test kits. The company offers more than 100 FDA cleared ELISA, immunofluorescence (IFA) and hemagglutination (HA) tests under their registered name VIRGO for diagnosis of the variety of autoimmune, infectious diseases and acute phase proteins. Hemagen Diagnosticos Comercio, Importacao e Exportacao, Ltda, located in Sao Paulo Brazil is a wholly owned subsidiary of Hemagen Diagnostics.
- Headquarters Columbia, United States
- Stage Public
- SectorsHealthcare
- Email••••••••
- Website hemagen.com
- Legal Name Hemagen Diagnostics Inc
- Annual Revenue$4.04 M (USD)-21as on Sep 30, 2012
- Net Profit-$907.32 K (USD)-3as on Sep 30, 2012
- EBITDA-$437.91 K (USD)7as on Sep 30, 2012
Products & Services of Hemagen
Hemagen offers a comprehensive portfolio of products and services, including Veterinary Diagnostic Products and Human Diagnostic Products.
Laboratory products for veterinary disease detection.
Tests for autoimmune and infectious diseases.
People of Hemagen
1 people are tracked at Hemagen (1 in leadership).
| Name | Role | Group |
|---|---|---|
William P. Hales | Chairman/President/CEO | Leadership |
Complete people profiles for Hemagen
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Hemagen
Hemagen is a publicly listed company on the OTC with ticker symbol HMGN in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date05 Feb 1995
- Listed onOTCMKTS: HMGN
- Listed entityHEMAGEN DIAGNOSTICS INC
- Exchange sectorHealth technology
- ISINUS4235011057
- Share price$0.00 · 2026-05-11
- Market capitalisation$3,100.00
- Volume (last session)5,000
- Analyst consensusNo rating
Web traffic of Hemagen
Websites that share an audience with Hemagen (hemagen.com).
Websites whose visitors overlap most with Hemagen. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| gracelaboratories.com | 100% | View details | |||
| trinitybiotech.com | 100% | 9.3K | #2,475,266 | View details | |
| nanogen.com | 84% | 13K | #1,627,585 | View details |
Top companies in Diagnostics & Lab Tech
3 companies that operate in the same segment as Hemagen (Diagnostics & Lab Tech) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
At-home health tests for biomarkers, nutrition, and hormone analysis. | 2014 | Austin, Texas, United States | USD 330 M | 336 | ||
Blood testing services are offered using finger-prick microsamples. | 2017 | Austin, Texas, United States | USD 37.7 M | |||
Manufactures clinical diagnostic test kits | 1971 | Irvine, California, United States | USD 4.45 M | 54 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Hemagen
Hemagen was founded in 1985.
Hemagen is headquartered in Columbia, United States.
Annual revenue of Hemagen is $4.04M as on Sep 30, 2012.
Hemagen Diagnostics is a biotechnology company focused on development and manufacturing of human and veterinary diagnostic test kits. The company offers more than 100 FDA cleared ELISA, immunofluorescence (IFA) and hemagglutination (HA) tests under their registered name VIRGO for diagnosis of the variety of autoimmune, infectious diseases and acute phase proteins. Hemagen Diagnosticos Comercio, Importacao e Exportacao, Ltda, located in Sao Paulo Brazil is a wholly owned subsidiary of Hemagen Diagnostics.
Hemagen offers Veterinary Diagnostic Products and Human Diagnostic Products.
Yes, Hemagen is publicly traded on OTC under the ticker symbol HMGN.
Hemagen operates through Hemagen Diagnostics Inc.